Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
Open Access
- 1 March 2012
- journal article
- Published by Taylor & Francis Ltd in Clinical and Experimental Gastroenterology
- Vol. 5, 23-34
- https://doi.org/10.2147/ceg.s25419
Abstract
Peer reviewed article authored by (Gisbert JP, Calvet X). Read article or submit your manuscript for publishing.Keywords
This publication has 85 references indexed in Scilit:
- 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trialThe Lancet, 2011
- Inhibition of Gastric Carcinogenesis by the Hormone Gastrin Is Mediated by Suppression of TFF1 Epigenetic SilencingGastroenterology, 2011
- Helicobacter pyloriInfectionNew England Journal of Medicine, 2010
- Sequential and Concomitant Therapy With Four Drugs Is Equally Effective for Eradication of H pylori InfectionClinical Gastroenterology and Hepatology, 2010
- Meta-analysis: Four-Drug, Three-Antibiotic, Non-bismuth-Containing "Concomitant Therapy" Versus Triple Therapy for Helicobacter pylori EradicationHelicobacter, 2009
- New concepts of resistance in the treatment of Helicobacter pylori infectionsNature Clinical Practice Gastroenterology & Hepatology, 2008
- The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysisGut, 2007
- American College of Gastroenterology Guideline on the Management of Helicobacter pylori InfectionThe American Journal of Gastroenterology, 2007
- Helicobacter pylori and antibiotic resistanceGut, 2007
- Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportGut, 2007